Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Cell Metabolism|August 6, 2025
Insulin signaling in microglia: A metabolic switch controlling neuroinflammation and amyloid pathology in Alzheimer's diseaseEugenio Barone, D Allan ButterfieldNeurobiology of Disease|March 4, 2015
Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?Eugenio Barone, D Allan ButterfieldBiogerontology|July 25, 2008
Ferulic acid and its therapeutic potential as a hormetin for age-related diseasesEugenio Barone, Vittorio Calabrese, Cesare MancusoJournal of Neural Transmission (Vienna, Austria : 1996)|May 31, 2025
Insulin resistance: fueling oxidative stress and neurodegenerationLaia Berridi Chamorro, Barbara Zulli, Eugenio BaronePharmacological Research|May 4, 2011
Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disordersD Allan Butterfield, Eugenio Barone, Cesare MancusoNeural Regeneration Research|September 11, 2014
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brainFabio Di Domenico, Marzia Perluigi, Eugenio BaroneBiochimica Et Biophysica Acta|October 16, 2014
Inactivation of brain Cofilin-1 by age, Alzheimer's disease and γ-secretaseEugenio Barone, Sebastien Mosser, Patrick C FraeringBiochimica Et Biophysica Acta|September 24, 2011
Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicineCesare Mancuso, Raffaella Siciliano, Eugenio Barone, et al.Molecular and Cellular Biochemistry|November 17, 2007
The protective role of carotenoids against 7-keto-cholesterol formation in solutionPaola Palozza, Eugenio Barone, Cesare Mancuso, et al.Biochemical Pharmacology|November 16, 2013
Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targetsEugenio Barone, Fabio Di Domenico, D Allan ButterfieldPageof 11